HBB and neoplasm: Expression of HBB was significantly elevated in >50% of CTCs from breast, prostate and lung cancers (Reads Per Million: RPMmedian=3,630, range (1.6–894,101); P=2.59E–07 for CTCs versus primary tumour and cancer cell lines) (Fig. 1b; Supplementary Fig. 1b).